NUVA logo

NuVasive (NUVA) Cash From Financing

Annual CFF

-$8.59 M
+$644.76 M+98.69%

31 December 2022

NUVA Cash From Financing Chart

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Quarterly CFF

-$96.80 M
-$61.90 M-177.35%

30 June 2023

NUVA Quarterly CFF Chart

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

TTM CFF

-$130.62 M
-$99.84 M-324.28%

30 June 2023

NUVA TTM CFF Chart

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

NUVA Cash From Financing Performance

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1 y1 year---
3 y3 years+98.7%-10000.0%+80.0%
5 y5 years-29.3%-7340.2%-1866.0%

NUVA Cash From Financing High & Low

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs lowTTM vs highTTM vs highTTM vs lowTTM vs low
3 y3 years
5 y5 years
alltimeall time-101.2%-123.6%-117.7%

NuVasive Cash From Financing History

DateAnnualQuarterlyTTM
June 2023
-
-$96.80 M(+177.4%)
-$130.62 M(+324.3%)
Mar 2023
-
-$34.90 M(-2314.6%)
-$30.79 M(+258.4%)
Dec 2022
-$8.59 M(-98.7%)
$1.58 M(-417.7%)
-$8.59 M(-10.0%)
Sept 2022
-
-$496.00 K(-116.3%)
-$9.54 M(-2.2%)
June 2022
-
$3.04 M(-123.9%)
-$9.76 M(-39.9%)
Mar 2022
-
-$12.71 M(-2136.1%)
-$16.23 M(-97.5%)
Dec 2021
-$653.35 M(-188.7%)
$624.00 K(-187.6%)
-$653.35 M(+0.0%)
Sept 2021
-
-$712.00 K(-79.3%)
-$653.03 M(+0.1%)
June 2021
-
-$3.44 M(-99.5%)
-$652.58 M(+172.8%)
Mar 2021
-
-$649.83 M(<-9900.0%)
-$239.23 M(-132.5%)
Dec 2020
$736.66 M(<-9900.0%)
$943.00 K(-454.5%)
$736.66 M(-0.1%)
Sept 2020
-
-$266.00 K(-100.1%)
$737.05 M(+0.1%)
June 2020
-
$409.92 M(+25.7%)
$736.19 M(+124.8%)
Mar 2020
-
$326.06 M(>+9900.0%)
$327.47 M(-5028.8%)
Dec 2019
-$6.64 M(-54.4%)
$1.34 M(-218.6%)
-$6.64 M(-41.6%)
Sept 2019
-
-$1.13 M(-193.8%)
-$11.37 M(-78.3%)
June 2019
-
$1.20 M(-114.9%)
-$52.48 M(-21.4%)
Mar 2019
-
-$8.06 M(+137.8%)
-$66.77 M(+358.0%)
Dec 2018
-$14.58 M(-83.2%)
-$3.39 M(-92.0%)
-$14.58 M(-69.4%)
Sept 2018
-
-$42.23 M(+222.5%)
-$47.59 M(-3.9%)
June 2018
-
-$13.10 M(-129.7%)
-$49.50 M(+51.1%)
Mar 2018
-
$44.14 M(-221.3%)
-$32.76 M(-62.4%)
Dec 2017
-$87.03 M(-178.5%)
-$36.40 M(-17.5%)
-$87.03 M(-39.7%)
Sept 2017
-
-$44.15 M(-1310.4%)
-$144.33 M(+41.9%)
June 2017
-
$3.65 M(-136.0%)
-$101.72 M(-7.3%)
Mar 2017
-
-$10.13 M(-89.2%)
-$109.71 M(-199.0%)
Dec 2016
$110.82 M(-465.2%)
-$93.71 M(+6024.7%)
$110.82 M(-45.4%)
Sept 2016
-
-$1.53 M(-64.8%)
$203.14 M(+0.6%)
June 2016
-
-$4.35 M(-102.1%)
$201.97 M(-0.1%)
Mar 2016
-
$210.41 M(<-9900.0%)
$202.07 M(-765.9%)
Dec 2015
-$30.34 M(-200.2%)
-$1.39 M(-48.5%)
-$30.34 M(+149.0%)
Sept 2015
-
-$2.70 M(-36.3%)
-$12.19 M(+35.7%)
June 2015
-
-$4.24 M(-80.7%)
-$8.98 M(-1562.5%)
Mar 2015
-
-$22.01 M(-231.3%)
$614.00 K(-98.0%)
Dec 2014
$30.28 M(-157.7%)
$16.77 M(+3226.6%)
$30.28 M(+13.5%)
Sept 2014
-
$504.00 K(-90.6%)
$26.67 M(-12.3%)
June 2014
-
$5.35 M(-30.1%)
$30.43 M(+3.7%)
Mar 2014
-
$7.66 M(-41.8%)
$29.35 M(-155.9%)
Dec 2013
-$52.48 M
$13.16 M(+209.2%)
-$52.48 M(-42.7%)
Sept 2013
-
$4.26 M(-0.4%)
-$91.52 M(-4.5%)
DateAnnualQuarterlyTTM
June 2013
-
$4.27 M(-105.8%)
-$95.79 M(-1.4%)
Mar 2013
-
-$74.17 M(+186.7%)
-$97.12 M(+330.6%)
Dec 2012
-$22.56 M(-110.7%)
-$25.87 M(>+9900.0%)
-$22.56 M(-29.5%)
Sept 2012
-
-$21.00 K(-100.7%)
-$31.99 M(-78.7%)
June 2012
-
$2.95 M(+655.4%)
-$149.91 M(-171.2%)
Mar 2012
-
$390.00 K(-101.1%)
$210.55 M(+0.3%)
Dec 2011
$209.88 M(+2863.6%)
-$35.30 M(-70.1%)
$209.88 M(-14.7%)
Sept 2011
-
-$117.94 M(-132.5%)
$246.10 M(-32.5%)
June 2011
-
$363.41 M(<-9900.0%)
$364.36 M(+9758.1%)
Mar 2011
-
-$284.00 K(-130.9%)
$3.70 M(-47.8%)
Dec 2010
$7.08 M(-51.0%)
$918.00 K(+193.3%)
$7.08 M(-35.6%)
Sept 2010
-
$313.00 K(-88.6%)
$11.00 M(-21.5%)
June 2010
-
$2.75 M(-11.4%)
$14.01 M(-14.6%)
Mar 2010
-
$3.10 M(-35.9%)
$16.40 M(+13.4%)
Dec 2009
$14.46 M(-93.4%)
$4.84 M(+45.7%)
$14.46 M(+11.1%)
Sept 2009
-
$3.32 M(-35.4%)
$13.02 M(+1.5%)
June 2009
-
$5.14 M(+342.8%)
$12.82 M(+14.9%)
Mar 2009
-
$1.16 M(-65.9%)
$11.16 M(-94.9%)
Dec 2008
$220.02 M(+3025.7%)
$3.40 M(+8.8%)
$220.02 M(+0.2%)
Sept 2008
-
$3.12 M(-10.2%)
$219.57 M(+0.9%)
June 2008
-
$3.48 M(-98.3%)
$217.65 M(+0.8%)
Mar 2008
-
$210.02 M(+7026.6%)
$215.88 M(+2967.0%)
Dec 2007
$7.04 M(-95.1%)
$2.95 M(+145.0%)
$7.04 M(+39.0%)
Sept 2007
-
$1.20 M(-29.8%)
$5.06 M(+12.8%)
June 2007
-
$1.71 M(+45.9%)
$4.49 M(+49.3%)
Mar 2007
-
$1.18 M(+20.9%)
$3.01 M(-97.9%)
Dec 2006
$144.37 M(+8187.3%)
$972.00 K(+54.8%)
$144.37 M(+0.2%)
Sept 2006
-
$628.00 K(+171.9%)
$144.09 M(+0.2%)
June 2006
-
$231.00 K(-99.8%)
$143.82 M(-0.3%)
Mar 2006
-
$142.53 M(>+9900.0%)
$144.18 M(+8176.6%)
Dec 2005
$1.74 M(-97.3%)
$693.00 K(+92.5%)
$1.74 M(+74.9%)
Sept 2005
-
$360.00 K(-39.2%)
$996.00 K(+68.8%)
June 2005
-
$592.00 K(+510.3%)
$590.00 K(-99.1%)
Mar 2005
-
$97.00 K(-283.0%)
$63.41 M(-1.2%)
Dec 2004
$64.18 M(+384.3%)
-$53.00 K(+15.2%)
$64.18 M(-0.1%)
Sept 2004
-
-$46.00 K(-100.1%)
$64.23 M(-0.1%)
June 2004
-
$63.41 M(+7171.7%)
$64.28 M(+7271.7%)
Mar 2004
-
$872.00 K
$872.00 K
Dec 2003
$13.25 M(+0.3%)
-
-
Dec 2002
$13.21 M
-
-

FAQ

  • What is NuVasive annual cash flow from financing activities?
  • What is the all time high annual CFF for NuVasive?
  • What is NuVasive quarterly cash flow from financing activities?
  • What is the all time high quarterly CFF for NuVasive?
  • What is NuVasive TTM cash flow from financing activities?
  • What is the all time high TTM CFF for NuVasive?

What is NuVasive annual cash flow from financing activities?

The current annual CFF of NUVA is -$8.59 M

What is the all time high annual CFF for NuVasive?

NuVasive all-time high annual cash flow from financing activities is $736.66 M

What is NuVasive quarterly cash flow from financing activities?

The current quarterly CFF of NUVA is -$96.80 M

What is the all time high quarterly CFF for NuVasive?

NuVasive all-time high quarterly cash flow from financing activities is $409.92 M

What is NuVasive TTM cash flow from financing activities?

The current TTM CFF of NUVA is -$130.62 M

What is the all time high TTM CFF for NuVasive?

NuVasive all-time high TTM cash flow from financing activities is $737.05 M